Epigenetic Therapy of Non-Small Cell Lung Cancer Using Decitabine (5-Aza-2′-Deoxycytidine)

por Momparler, Richard L.
Publicado 2013

Optimization of cytarabine (ARA-C) therapy for acute myeloid leukemia

por Momparler, Richard L
Publicado 2013

A Perspective on the Comparative Antileukemic Activity of 5-Aza-2′-deoxycytidine (Decitabine) and 5-Azacytidine (Vidaza)

por Momparler, Richard L.
Publicado 2012

Pharmacokinetic and pharmacodynamic analysis of 5-aza-2’-deoxycytidine (decitabine) in the design of its dose-schedule for cancer therapy

por Karahoca, Metin, Momparler, Richard L
Publicado 2013

Preclinical evaluation of the antineoplastic action of 5-aza-2'-deoxycytidine and different histone deacetylase inhibitors on human Ewing's sarcoma cells

por Hurtubise, Annie, Bernstein, Mark L, Momparler, Richard L
Publicado 2008

Epigenetic Modulation of Self-Renewal Capacity of Leukemic Stem Cells and Implications for Chemotherapy

por Momparler, Richard L., Côté, Sylvie, Momparler, Louise F.
Publicado 2020

Enhancement of the Antileukemic Action of the Inhibitors of DNA and Histone Methylation: 5-Aza-2′-Deoxycytidine and 3-Deazaneplanocin-A by Vitamin C

por Momparler, Richard L., Côté, Sylvie, Momparler, Louise F.
Publicado 2021

Epigenetic therapy of acute myeloid leukemia using 5-aza-2'-deoxycytidine (decitabine) in combination with inhibitors of histone methylation and deacetylation

por Momparler, Richard L, Côté, Sylvie, Momparler, Louise F, Idaghdour, Youssef
Publicado 2014

Inhibition of DNA and Histone Methylation by 5-Aza-2′-Deoxycytidine (Decitabine) and 3-Deazaneplanocin-A on Antineoplastic Action and Gene Expression in Myeloid Leukemic Cells

por Momparler, Richard L., Côté, Sylvie, Momparler, Louise F., Idaghdour, Youssef
Publicado 2017

Importance of dose-schedule of 5-aza-2'-deoxycytidine for epigenetic therapy of cancer

por Lemaire, Maryse, Chabot, Guy G, Raynal, Noël JM, Momparler, Louise F, Hurtubise, Annie, Bernstein, Mark L, Momparler, Richard L
Publicado 2008